HNPCC Clinical Trials HNPCC RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients
Condition:   Lynch Syndrome Interventions:   Biological: Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP;   Biological: MVA Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP;   Other: Questionnaire Administration Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 15, 2021 Category: Research Source Type: clinical trials

Overcoming Barriers to the Uptake of Cascade Screening for Lynch Syndrome: Workbook Feasibility Study
Condition:   Lynch Syndrome Intervention:   Behavioral: Educational Workbook Sponsors:   UNC Lineberger Comprehensive Cancer Center;   National Center for Advancing Translational Science (NCATS);   University of North Carolina, Chapel Hill;   North Carolina Translational and Clinical Sciences Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2021 Category: Research Source Type: clinical trials